A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Intravenous NA-1 in Subjects With Acute Ischemic Stroke
- Result Type
- clinical trial
The ESCAPE-NA-1 study is designed to determine the safety and efficacy of the neuroprotectant, NA-1